Every record from Janoshik · page 9
The single largest contributor to the index and the de facto reference against which the other five labs are calibrated here. Measured offset against the reference laboratory is 0.000 pp. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042930 | L-Glutathione (reduced) | MKM | MKM-2511-F2902 | 2026-Q2 | 98.42 | 7.82 | 97.4 | Supplier-supplied | 1 | FAIL |
| AX-2026-042757 | TB-500 | GGPeps | GGPE-2601-B9932 | 2026-Q2 | 99.65 | 4.46 | 102.4 | Supplier-supplied | 2 | FAIL |
| AX-2026-041363 | Tirzepatide | WWB | WWB-2604-T3876 | 2026-Q2 | 99.54 | 4.61 | 90.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041211 | NAD+ | WWB | WWB-2601-V1583 | 2026-Q2 | 99.93 | 11.52 | 92.9 | Supplier-supplied | 0 | FAIL |
| AX-2026-043416 | MOTS-c | WXT | WXT-2511-P4848 | 2026-Q2 | 98.23 | 5.14 | 106.7 | Supplier-supplied | 0 | PASS |
| AX-2026-043149 | MOTS-c | SSA | SSA-2511-W7415 | 2026-Q2 | 98.00 | 5.42 | — | Supplier-supplied | 0 | PASS |
| AX-2026-043098 | Epitalon | KP | KP-2512-R5829 | 2026-Q2 | 97.71 | 6.99 | — | Supplier-supplied | 2 | FAIL |
| AX-2026-042300 | AOD-9604 | HJ | HJ-2601-N2483 | 2026-Q2 | 98.77 | 5.32 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-041246 | GHK-Cu | WWB | WWB-2512-B1996 | 2026-Q2 | 98.85 | 5.71 | 89.8 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042988 | Desmopressin | KP | KP-2512-U5139 | 2026-Q2 | 98.72 | 3.00 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042808 | Retatrutide | GGPeps | GGPE-2603-M1446 | 2026-Q2 | 98.19 | 4.08 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042643 | IGF-1 LR3 | GGPeps | GGPE-2604-K8140 | 2026-Q2 | 98.10 | 2.36 | 109.0 | Laboratory-retained | 0 | PASS |
| AX-2026-042637 | IGF-1 LR3 | GGPeps | GGPE-2604-K8140 | 2026-Q2 | 98.47 | 2.20 | — | Supplier-supplied | 0 | PASS |
| AX-2026-042336 | L-Glutathione (reduced) | HJ | HJ-2511-F3082 | 2026-Q2 | 99.93 | 7.34 | — | Supplier-supplied | 0 | PASS |
| AX-2026-042038 | Gonadorelin | TFC | TFC-2511-E6450 | 2026-Q2 | 99.03 | 2.63 | 101.8 | Supplier-supplied | 0 | PASS |
| AX-2026-042039 | Gonadorelin | TFC | TFC-2511-E6450 | 2026-Q2 | 99.39 | 2.81 | 96.2 | Supplier-supplied | 0 | PASS |
| AX-2026-041743 | TB-500 | FGP | FGP-2512-Y9750 | 2026-Q2 | 99.37 | 3.31 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043260 | BPC-157 | SGN | SGN-2512-H1950 | 2026-Q2 | 98.53 | 4.71 | 100.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043224 | SLU-PP-332 | SGN | SGN-2602-X9969 | 2026-Q2 | 98.82 | 6.07 | 98.3 | Supplier-supplied | 0 | PASS |
| AX-2026-043187 | PT-141 (Bremelanotide) | GL Biochem | GLBI-2511-F8417 | 2026-Q2 | 97.97 | 2.82 | — | Supplier-supplied | 2 | FAIL |
| AX-2026-043021 | Semaglutide | KP | KP-2511-J4998 | 2026-Q2 | 99.65 | 8.21 | 104.2 | Supplier-supplied | 1 | FAIL |
| AX-2026-042936 | Semaglutide | MKM | MKM-2601-Y3343 | 2026-Q2 | 98.21 | 3.33 | — | Supplier-supplied | 3 | MARGINAL |
| AX-2026-042437 | IGF-1 DES (1-3) | SWB | SWB-2601-Y5870 | 2026-Q2 | 97.72 | 4.18 | 98.0 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042434 | IGF-1 DES (1-3) | SWB | SWB-2601-Y5870 | 2026-Q2 | 98.00 | 4.05 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042267 | Liraglutide | Homopeptide | HOMO-2602-E2761 | 2026-Q2 | 99.93 | 3.53 | — | Supplier-supplied | 1 | FAIL |
| AX-2026-041775 | SS-31 (Elamipretide) | FGP | FGP-2601-R1916 | 2026-Q2 | 99.72 | 5.06 | 96.7 | Supplier-supplied | 0 | PASS |
| AX-2026-041709 | Hexarelin | QSC | QSC-2601-N9656 | 2026-Q2 | 99.84 | 5.39 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041606 | Pinealon | QSC | QSC-2602-V8219 | 2026-Q2 | 99.90 | 7.67 | 104.1 | Supplier-supplied | 0 | FAIL |
| AX-2026-041303 | Ipamorelin | WWB | WWB-2604-E3153 | 2026-Q2 | 99.93 | 5.92 | — | Supplier-supplied | 0 | PASS |
| AX-2026-043498 | MOTS-c | BCH | BCH-2511-L5815 | 2026-Q2 | 96.96 | 3.75 | 93.4 | Supplier-supplied | 0 | FAIL |
| AX-2026-043213 | Thymosin α1 | SGN | SGN-2512-Y1213 | 2026-Q2 | 99.13 | 7.01 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-043135 | BPC-157 | SSA | SSA-2601-N6752 | 2026-Q2 | 98.25 | 4.56 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042697 | Retatrutide | GGPeps | GGPE-2512-D9394 | 2026-Q2 | 98.24 | 3.90 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042334 | Ipamorelin | HJ | HJ-2604-T3574 | 2026-Q2 | 98.77 | 5.51 | — | Supplier-supplied | 1 | FAIL |
| AX-2026-042118 | PT-141 (Bremelanotide) | TFC | TFC-2512-M8211 | 2026-Q2 | 99.13 | 7.21 | 101.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041350 | BPC-157 | WWB | WWB-2604-B3510 | 2026-Q2 | 99.93 | 4.65 | 89.4 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042999 | TB-500 | KP | KP-2605-C4659 | 2026-Q2 | 99.43 | 4.83 | 97.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042583 | SLU-PP-332 | GGPeps | GGPE-2511-R8569 | 2026-Q2 | 98.92 | 4.11 | 91.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042329 | Tirzepatide | HJ | HJ-2605-D3120 | 2026-Q2 | 98.04 | 4.55 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041956 | BPC-157 | TFC | TFC-2604-A4630 | 2026-Q2 | 99.47 | 5.44 | 103.5 | Supplier-supplied | 1 | MARGINAL |